摘要
目的 :研究肾病综合征患者在治疗前后抗凝血酶Ⅲ (AT -Ⅲ )的变化及临床价值。方法 :分正常对照组、肾病综合征治疗前及治疗后三组 ,应用全自动血凝仪测定AT -Ⅲ活性。结果 :肾病综合征治疗前比正常对照组明显降低 (P <0 0 1) ,肾病综合征治疗后AT -Ⅲ含量明显升高 ,与治疗前及正常对照组比较有显著性差异 (P <0 0 1)。结论 :对肾病综合征患者抗凝血酶Ⅲ含量的检测 ,有助于临床治疗及疗效观察 。
Objective:To study the change and clinical significance of antithrombin Ⅲ(AT-Ⅲ) and its clinical value in nephropathy syndrome patients before and after treatment.Methods:The automatic blood coagulation instrument was applied to quantitatively analyze antithrombin Ⅲ in these three groups:normal control group,nephropathy syndrome group before treatment and nephropathy syndrome group after treatment.Results:The antithrombin Ⅲ of nephropathy syndrome group before treatment is obviously lower than that of normal control group(P<0 01).The antithrombin-Ⅲ of nephropathy syndrome group after treatment rises clearly,which exists a significant difference comparing with nephropathy syndrome group before treatment and normal control group(P<0 01).Conclusion:the determination of antithrombin Ⅲ content in nephropathy syndrome patients is helpful to clinic treatment,its results observation and thrombosis preventiont.
出处
《广西医学》
CAS
2002年第6期815-816,共2页
Guangxi Medical Journal
